Corcept Therapeutics | CORT - Ebitda



Corcept Therapeutics reported $27.14M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Acadia Pharmaceuticals USD 35.31M 13.07M Jun/2025
Alaunos Therapeutics USD 16.01M 17.16M Oct/2024
ANI Pharmaceuticals USD 54.08M 5.72M Jun/2025
Ardelyx USD -11872000 20.51M Jun/2025
Aurora Cannabis CAD -11427000 13.94M Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Canopy Growth CAD -21827000 13.2M Jun/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Knight Therapeutics CAD 16.72M 1.05M Sep/2024
Merck USD 7.74B 625M Mar/2025
Novartis USD 6.17B 339M Jun/2025
Novartis USD 6.08B 739M Jun/2025
Pacira USD 54.32M 24.98M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Supernus Pharmaceuticals USD 41.47M 23.68M Jun/2025
TG Therapeutics USD 12.28M 17.68M Mar/2025